iBio
IBIO
#10001
Rank
S$0.10 B
Marketcap
S$1.63
Share price
2.40%
Change (1 day)
47.84%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): S-$0.99

According to iBio's latest financial reports the company's current EPS (TTM) is S-$0.96. In 2025 the company made an earnings per share (EPS) of S-$2.23 an increase over its 2024 EPS that were of S-$8.29.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.99-55.53%
2025S-$2.23-73.08%
2024S-$8.29-93.88%
2023S-$135.47-8.14%
2022S-$147.4792.67%
2021S-$76.54-80.33%
2020S-$389.09-35.11%
2019S-$599.58-38.96%
2018S-$982.29-6.1%
2017S-$1,04636.67%
2016S-$765.4233.33%
2015S-$574.0650%
2014S-$382.71-53.85%
2013S-$829.20-7.14%
2012S-$892.99-64.1%
2011S-$2,48877.27%
2010S-$1,403144.44%
2009S-$574.0612.93%
2008S-$508.3512.2%
2007S-$453.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.14-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
S-$0.66-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$10.74 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$0.22-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA